Public log · Updated August 18, 2026
Changelog
What we've changed, verified, and shipped on GLP-1 Picks.
- Every provider re-verification
- Every new article
- Every methodology update
Reverse-chronological, append-only, public on day one. The long version of our editorial policy.
August 2026 · 20 entries
- August 14Provider re-verified
Eden Health GLP-1 review, re-verified
Eden Health offers unusually deep clinical oversight, with board-certified obesity medicine doctors and quarterly labs, but that strength no longer supports an unqualified recommendation. FDA warning letter #728279 cites false or misleading compounded-GLP-1 marketing claims; it i…
- August 14Provider re-verified
TrimRx review, re-verified
TrimRx is legitimate in the narrow sense that it is an operating telehealth provider, but the evidence no longer supports a best-value recommendation. Its $179 landing-page floor conflicts with an official terms schedule of $199 then $299 for semaglutide and $349 then $399 for GL…
- August 14Provider re-verified
MEDVi review, re-verified
MEDVi has real strengths, especially oral-to-injectable flexibility and a large 4.4/5 Trustpilot record, but it is not a low-risk recommendation. The $179 semaglutide headline becomes $299 from month two, the BBB grade is F, and FDA warning letter #721455 has no public close-out…
- August 14Provider re-verified
Maximus review, re-verified
Maximus has a low published microdose medication price, but not the lowest verified all-in program: the $79.99 microdose and $99.99 starter exclude $28-35 consultations and $199-349 annual labs. FDA warning letter #730095 over compounded-GLP-1 marketing claims is also part of the…
- August 14Provider re-verified
Embody review, re-verified
Embody works when you buy it with the plan term visible. The oral tirzepatide gum remains a rare differentiator, the 6-month satisfaction policy is published, and four pharmacy partners are named. The current injection offer is semaglutide from $79 and GLP-1 + GIP from $129, but…
- August 14Provider re-verified
Hims review, re-verified
Hims has the strongest brand recognition and one of the few direct Novo Nordisk partnerships for FDA-approved Wegovy. But the verified Trustpilot rating (3.0 across 8,286 reviews, 28% 1-star) is the weakest in our table, the lowest customer-experience signal among major affiliate…
- August 14Provider re-verified
Hers review, re-verified
Hers offers a broad menu inside a female-focused platform, including FDA-approved Wegovy, Ozempic, Foundayo, and Zepbound paths plus compounded options. The honest floor is not the $149 medication number by itself: the required membership makes that path $188 in month one and $29…
- August 14Provider re-verified
Gala review, re-verified
Gala earns its spot on two genuine strengths: a clearly separated tirzepatide microdose tier and a dedicated tracker app on BOTH iOS and Android. Price depends on commitment: $149 microdose or $179 full dose on a yearly plan, versus $169 or $219 on a 3-month plan. OpenLoop-affili…
- August 14Provider re-verified
SkinnyRx review, re-verified
SkinnyRx has unusual medication-format breadth, but FDA warning letter #717989 and the lack of a named medical director or dispensing pharmacy prevent an unqualified recommendation. The letter cites misleading labeling and marketing, not an unsafe-medication finding, and is refle…
- August 14Provider re-verified
Telos RX review, re-verified
Telos RX has genuine strengths: a stated four-hour review window, 24/7 clinical messaging, clinician-managed titration, oral tirzepatide with ondansetron, and two named pharmacies. But the August 1 terms remove two credits the prior review gave it. Consultations and ordered labs…
- August 12Provider re-verified
SnagRx review, re-verified
SnagRx is worth comparing on its $69 medication floor, and only with your eyes open. It names its pharmacy, publishes a refund policy and shows the advertised medication price without making you start an intake, but its terms refer to a non-refundable medical consult fee, so the…
- August 5Article shipped
Retatrutide TRIUMPH-1 Results (May 2026): 30.3% Weight Loss, Phase 3 Primary Trial
Updated August 5, 2026: Added Lilly's ClinicalTrials.gov expanded-access record (NCT07629401), registered June 5, 2026, which lists no eligibility criteria. Biologic classification lawsuit context (Lilly v. FDA, Case 1:24-cv-01503). Obesity (TRIUMPH-1): 28.3% weight loss at 80 we…
- August 4Article shipped
Serena Williams’ Tennis Comeback and Zepbound: What’s Confirmed, What Isn’t, and What WADA Actually Says
Serena Williams disclosed GLP-1 treatment and a commercial Ro relationship in 2025, then returned to professional tennis in 2026. No cited official source confirms current Zepbound use. Here is the dated evidence and the difference between WADA monitoring and prohibition.
- August 4Article shipped
Can GLP-1 Treatment Be Personalized? What New Penn and Mayo Studies Actually Show
A Penn-led analysis compared seven cardiometabolic outcomes across GLP-1 trial programs, while Mayo researchers identified a possible obesity phenotype associated with a different retrospective tirzepatide response. Together they sharpen the research questions, but they do not cr…
- August 3Provider re-verified
Direct Meds GLP-1 review, re-verified
Direct Meds publishes an easy-to-compare format-specific bill: $297/mo for compounded semaglutide injection, $399/mo for tirzepatide injection, and $179/$224 for the sublingual formats. Its 4.6/5 merged Trustpilot profile across 13,114 reviews is substantial, but so is the confli…
- August 2Article shipped
Alcohol and GLP-1 Medications: Risks, Cravings, and What the Labels Leave Out
Neither the Wegovy nor the Zepbound prescribing information mentions alcohol. This is what the labels do say about hypoglycemia and nausea, what the craving research has and has not shown, and what changes if you also take insulin or a sulfonylurea.
- August 2Article shipped
Berberine vs Ozempic: Why Berberine Is Not "Nature's Ozempic"
Berberine picked up the nickname "nature's Ozempic" on TikTok. The two compounds act on different targets, and the meta-analysis that looked directly at body weight found no significant effect.
- August 2Article shipped
GLP-1 Storage and Travel: Heat, TSA Rules, and What to Do If It Was Left Out
What the Ozempic, Wegovy, Mounjaro and Zepbound labels actually say about the fridge, the counter, a hot car, a freezer, and an airport checkpoint. Each answer is in the first sentence, because you are probably reading this in a hurry.
- August 2Article shipped
How to Get Semaglutide Online in 2026: The Legal Route and the Red Flags
Every legal route to semaglutide runs through a licensed prescriber and a licensed pharmacy. This is the decision tree: how legitimate telehealth flows work, brand versus compounded, and the red flags that mark an illegal seller.
- August 2Article shipped
Ozempic Plateau: Why You Stopped Losing Weight
A weight plateau on semaglutide or tirzepatide has four separate causes, and they do not share an answer. Here is how to tell which one you are looking at, using what the STEP and SURMOUNT trials actually measured.
July 2026 · 14 entries
- July 31Provider re-verified
AgelessRx review, re-verified
AgelessRx is genuinely different: its longevity-medicine framework, microdosing protocols, and no-membership model set it apart from cookie-cutter GLP-1 platforms. The published semaglutide + B12 price is $199/mo and tirzepatide + B12 is $249/mo, each with a separate $50/mo clini…
- July 18Provider re-verified
HealthRX review, re-verified
HealthRX earns a provisional 5.2/10. Pricing and user flow are the strengths: $99/mo semaglutide, flat dosing, included clinician review, linked LegitScript verification, nationwide access, overnight shipping, and one-click cancellation. Public accountability is the weakness. The…
- July 18Editorial / methodology
Provider count 52 to 53, HealthRX added
Added HealthRX (healthrx.com) through Katalys offer 1630 after a rubric-first public-source audit. The provisional 5.2/10 score credits low flat-dose pricing, nationwide access, linked LegitScript verification, and a clear cancellation path. It also reflects the unnamed pharmacy,…
- July 17Article shipped
Semaglutide Before and After: Weight Loss Results by Month
Clinical trials show 14.9-20.7% body weight loss with semaglutide depending on dose. Standard Wegovy (2.4mg): 14.9-17% over 68 weeks. Wegovy HD (7.2mg, FDA-approved March 2026): 20.7% over 72 weeks. Month-by-month breakdown from the STEP trials.
- July 16Article shipped
Foundayo vs Wegovy Pill (2026): Weight Loss, Dosing & From-$149 Prices
Updated August 14, 2026: Oral Wegovy produced 16.6% weight loss in OASIS vs Foundayo's 12.4% in ATTAIN-1; these were separate trials. Both manufacturer-direct cash-pay floors now start at $149/mo. Foundayo follows a $149-$349 dose/refill ladder and requires no fasting; NovoCare's…
- July 15Article shipped
Semaglutide vs Tirzepatide (2026): 13.7% vs 20.2% Weight Loss, Head-to-Head SURMOUNT-5
Updated July 2026: Tirzepatide produces 20.2% weight loss vs semaglutide's 13.7% in the SURMOUNT-5 head-to-head trial (NEJM 2024): a 47% greater relative reduction confirmed by 2026 systematic meta-analyses. Tirzepatide activates GLP-1 + GIP dual receptors; semaglutide activates…
- July 9Article shipped
Oral GLP-1 Weight Loss Pills (2026): Foundayo, Oral Semaglutide (Wegovy) & All Options Compared
As of August 2026, two FDA-approved oral GLP-1 weight-loss pills exist: Foundayo (orforglipron, 12.4% in ATTAIN-1, LillyDirect from $149/mo at 0.8 mg with a dose/refill ladder to $349, no fasting) and the Wegovy pill (semaglutide 25mg, 16.6% in OASIS, NovoCare from $149/mo, dose-…
- July 7Article shipped
Wegovy vs Zepbound (June 2026): SURMOUNT-5 Head-to-Head, Wegovy HD, & Cost Comparison
Updated August 2026: SURMOUNT-5 head-to-head trial (NEJM): Zepbound 20.2% vs Wegovy 13.7% weight loss at 72 weeks. Wegovy HD (7.2mg, FDA-approved March 2026) closes the gap at 20.7%. NovoCare lists the Wegovy pen at $199/mo for the first two low-dose fills, then $349/mo at standa…
- July 6Article shipped
GLP-1 Cost 2026: Wegovy, Zepbound & Ozempic Prices ($25 to $1,350/mo)
How much do GLP-1 medications cost in 2026? Wegovy, Zepbound, Ozempic, Mounjaro & Foundayo range from $25 to $1,350/month. With insurance + savings card: $25/mo. Without insurance: $146/mo compounded sema (Yucca Health), $149/mo Foundayo pill, $299 to 449/mo brand injectable (Lil…
- July 6Article shipped
Medicare GLP-1 Coverage July 2026: $50/mo Wegovy + Zepbound Bridge Program Guide
Updated July 2026: Medicare Part D now covers Foundayo, Wegovy, and Zepbound for weight loss (live since July 1, 2026) via the Medicare GLP-1 Bridge program. Flat $50/month copay. About 3.8 million Part D enrollees are eligible (KFF, June 2026). Both oral pills (Foundayo and Wego…
- July 3Article shipped
Medicare GLP-1 Coverage: Everything Changing in July 2026
Medicare GLP-1 coverage is NOW LIVE as of July 1, 2026. Here's who qualifies for the $50/month Bridge program, how to get prior auth, and whether the Bridge beats cash-pay (our 54-provider price audit).
- July 2Provider re-verified
Trimi Health review, re-verified
Trimi Health is a pricing-first pick with a reputation problem. The structure is genuinely strong: flat pricing across doses, consult and overnight shipping included, $99/mo semaglutide on the annual plan, a named medical director, and named pharmacies. But the third-party record…
- July 2Provider re-verified
LivBody review, re-verified
LivBody is a known supplement brand renting telehealth machinery, and the rubric score, 2.9/10, the lowest we track, reflects how little of the GLP-1 program you can verify before paying. Credit where due: four named pharmacies with street addresses, a named medical group, consul…
- July 2Article shipped
Ozempic vs Wegovy (2026): Same Drug, $1,028 vs $1,349 List, Here's Which You Need
Verified August 14, 2026: Ozempic and Wegovy are both semaglutide from Novo Nordisk. Ozempic ($1,027.51/mo list) is approved for type 2 diabetes at max 2mg. Wegovy ($1,349/mo list) is approved for weight loss at max 2.4mg (or 7.2mg HD). NovoCare lists each pen at $199/mo for the…
June 2026 · 7 entries
- June 24Article shipped
Mounjaro vs Ozempic (2026): The Honest Head-to-Head Your Doctor Won't Have Time For
Mounjaro (tirzepatide) and Ozempic (semaglutide) are both FDA-approved only for type 2 diabetes, neither is approved for weight loss (that's their sister brands, Zepbound and Wegovy). In the first head-to-head trial, SURMOUNT-5, tirzepatide beat semaglutide for weight loss (−20.2…
- June 24Article shipped
GLP-1 for PCOS (2026): Ozempic, Wegovy & Cheaper Compounded Paths
GLP-1 medications like Ozempic and Wegovy can help PCOS because the syndrome is driven by insulin resistance, and these drugs improve insulin sensitivity, drive weight loss, and in trials restored menstrual regularity and raised natural-pregnancy rates. But here is the catch almo…
- June 19Article shipped
Compounded Semaglutide After the Shortage: FDA Enforcement and Switch Options
FDA resolved the semaglutide shortage on February 21, 2025 and ended temporary shortage-based enforcement discretion on April 22 for 503A pharmacies and May 22 for 503B facilities. This guide separates those dates from FDA's pending 503B bulk-list proposal and compares paths to d…
- June 16Article shipped
CagriSema 2026: Weight Loss Results, FDA Timeline & Why You Can't Buy It Yet
CagriSema (cagrilintide + semaglutide) lost 22.7% average body weight in adults with obesity (REDEFINE 1) and 13.7% in adults with type 2 diabetes (REDEFINE 2) over 68 weeks. Novo Nordisk filed its US application on December 18, 2025; an FDA decision is expected later in 2026 wit…
- June 11Article shipped
Medicare GLP-1 Bridge Enrollment Guide 2026: $50 Copay for Foundayo, Wegovy & Zepbound
Updated June 11, 2026: CMS released the official prior authorization request form (cms.gov/glp-1-bridge.pdf, June 8) revealing a key eligibility nuance, beneficiaries with OSA, MASH, T2D, or established CVD are NOT eligible for the Bridge (they route through regular Part D instea…
- June 2Editorial / methodology
Provider count 48 → 49, FeelGood added
Added FeelGood (feelgoodmeds.com), a budget compounded-semaglutide telehealth platform ($149/mo starting injection, $249/mo oral tablet), scored 7.0 by the published methodology. Its LegitScript approval and money-back guarantee are genuine strengths; undisclosed state coverage a…
- June 1Provider re-verified
FeelGood review, re-verified
FeelGood earns a place in the budget tier on price and access: $149/mo starting for compounded semaglutide, a $249/mo oral tablet route, free shipping, no membership fee, a money-back guarantee, and LegitScript approval, a stronger trust signal than most cheap compounded shops ca…
May 2026 · 45 entries
- May 17Provider re-verified
Willow review, re-verified
Willow is a solid mid-tier compounded-only GLP-1 platform. At $299/mo compounded semaglutide (injectable or daily oral) and $399/mo compounded tirzepatide, pricing is above ultra-cheap options like Lemonaid Health but reflects real clinical oversight. The oral semaglutide daily t…
- May 17Provider re-verified
Sprout Health review, re-verified
Sprout Health suits buyers who want one dedicated point of contact through their whole titration, backed by published outcomes data. Go in with eyes open: the external review record is weak, so lean on the protections, $199 first month, cancel anytime, and a 30-day refund on unus…
- May 17Provider re-verified
Fridays review, re-verified
Fridays is the best choice for users with GLP-1 insurance coverage, the direct billing can bring costs down to $25-50/mo, which is unbeatable. The nutrition coaching adds genuine value for users who want more than just medication. Without insurance, the $249/mo price is harder to…
- May 17Provider re-verified
Ro review, re-verified
Ro is the safest bet for insured users who want brand-name GLP-1 medications from a trusted platform. The speed, insurance integration, and brand recognition are unmatched. The trade-off is no compounded options and high self-pay prices, if you don't have insurance coverage, plat…
- May 17Provider re-verified
Enhance MD review, re-verified
Enhance MD is the smart budget choice for self-directed users who know what they want. The $49-first-month, $212/mo-ongoing entry for both medication types is competitive (wafers from $84/mo on the 6-month plan), and the combination therapy options are a unique bonus. First-timer…
- May 17Provider re-verified
Sesame Care review, re-verified
Sesame Care is the most cost-effective path to a GLP-1 prescription for insured patients: $25 per consultation, no subscription lock-in, and the broadest FDA-approved brand-name menu in the low-cost tier (Wegovy pen and pill, Zepbound, Foundayo). Uninsured users who want one bund…
- May 17Provider re-verified
Strut Health review, re-verified
Strut Health owns a broad needle-free menu: oral semaglutide from $99/mo, oral tirzepatide at $199/mo, and auto-refill injectables if you switch. Two trade-offs must stay beside that price: Strut does not publish evidence establishing its compounded oral products as bioequivalent…
- May 17Provider re-verified
Ivim Health review, re-verified
Ivim restructured into package pricing, sema at $900 for 12 months (plus $75 mandatory membership) works out to $150/mo all-in, which is competitive. Tirz at $1,600 for 12 months is $208/mo all-in. Klarna financing available. Best for users who can commit to 6-12 months upfront.
- May 17Provider re-verified
bmiMD review, re-verified
bmiMD trades on scale: 80,000+ customers and same-day physician consults give it a maturity newer platforms lack. Pricing rewards commitment: the 12-month plan brings semaglutide to about $99/mo, the TAKEOFF 3-month plan runs about $119/mo, and month-to-month (no commitment) is $…
- May 17Provider re-verified
Hone Health review, re-verified
Hone Health is the most medically thorough option on this list, the 40+ biomarker panel is genuinely more comprehensive than any competitor's intake process. But the layered pricing ($65 + $149/mo + medication) makes it 2-3x the cost of focused weight-loss platforms. Best for pat…
- May 17Provider re-verified
Found review, re-verified
Found is the clear winner for insured patients. The insurance coordination service and GLP-1 coverage check are features most competitors simply don't offer, and the 10+ medication toolkit gives clinicians flexibility single-medication platforms can't match. The cash-pay total is…
- May 17Provider re-verified
MyStart Health review, re-verified
MyStart Health delivers the thing it promises: a monthly rate that locks in and never rises with your dose, at a competitive $149-179/mo with unlimited access to a 600+ doctor network. It's cash-pay, compounded-only, and select-state; insured patients get more from platforms like…
- May 17Provider re-verified
Fella Health review, re-verified
Fella's brand-name-only approach is a bold bet on quality over price. The 6-month money-back guarantee is one of the strongest in the industry and shows real confidence. At $165/mo with a year commitment, it's actually competitive for brand-name GLP-1 access. The men-only focus m…
- May 17Provider re-verified
TMates review, re-verified
TMates gives you two distinct ways to buy: all-in compounded GLP-1s at $158/mo on the 12-month plan (or $249 month-to-month), and a $99/mo clinical service for brand Wegovy/Zepbound where your own pharmacy dispenses the drug. Know which model you're buying: the $99 tier covers th…
- May 17Provider re-verified
Mochi Health review, re-verified
Mochi Health is the best value play for patients planning to stay on GLP-1 long-term at therapeutic doses. The flat $99/mo pricing saves real money compared to platforms that scale with dose. Four semaglutide formats and registered dietitian access are unique differentiators. The…
- May 17Provider re-verified
Elevate Health review, re-verified
Elevate Health's oral semaglutide at $114/mo is a standout price point, and the BNPL financing removes a real barrier for patients who can't afford $200+/mo upfront. Free blood work adds clinical value. The risk is promo-dependent pricing, lock in rates before enrolling and under…
- May 17Provider re-verified
DudeMeds review, re-verified
DudeMeds is the simplest GLP-1 platform to use: $199/mo all-in, 48-hour shipping, no appointments to schedule. The undisclosed company details (no public HQ, no founding date) are worth a question to support before you order, and first-timers who need guidance should look at plat…
- May 17Provider re-verified
Zealthy review, re-verified
Zealthy is built for insured patients. If the coordinators get your brand-name GLP-1 covered, you're looking at potentially $25/mo, value no cash-pay platform can touch, and multi-month supplies up to 12 months are a convenience most competitors can't offer. The company is young…
- May 17Provider re-verified
SynergyRx review, re-verified
The oral dissolving tablet format for both semaglutide and tirzepatide sets SynergyRx apart from most competitors, and free expedited shipping plus 24/7 support strengthen the package. Weigh that against limited reviews and an undisclosed company history, and get pharmacy partner…
- May 17Provider re-verified
PeterMD review, re-verified
PeterMD delivers genuine value at $165/mo flat with a semaglutide + B12 formulation that addresses the nausea problem most patients fear, backed by a 100,000+ patient base and strong Trustpilot reviews. The 42-state footprint and lack of BBB accreditation keep it from the top tie…
- May 17Provider re-verified
MangoRx review, re-verified
MangoRx owns a specific niche: oral-only GLP-1 with public-company accountability, and the NASDAQ listing is a genuine trust signal. At $299-399/mo for compounded oral tablets versus $99-179/mo injectable alternatives, you're paying a clear premium for the needle-free format, so…
- May 17Provider re-verified
Care Bare Rx review, re-verified
CareBareRX's flat $199/mo for both oral and injectable options is refreshingly straightforward, and the named physician leadership adds a trust layer most small platforms lack. The company publishes little about itself (no founding date, headquarters, pharmacy partners, or meanin…
- May 17Provider re-verified
Breeze Meds review, re-verified
The no-subscription model is BreezeMeds' main selling point: month-by-month ordering with no billing commitments, which suits patients burned by hard-to-cancel subscriptions elsewhere, and the three formulation options add real choice. Do your homework first: confusingly similar…
- May 17Provider re-verified
Noom Med review, re-verified
Noom Med is the best choice for users who believe lasting weight loss requires behavior change alongside medication. The coaching methodology is research-backed and the integration with GLP-1s is thoughtful. At $249/mo without insurance, it's expensive if you mainly want the medi…
- May 17Provider re-verified
GobyMeds review, re-verified
GobyMeds is the best budget pick for compounded semaglutide in 2026. The $169/mo standard monthly rate (or $99/mo on the 3-month starter bundle), fast delivery, and strong user reviews make it a standout value. In 2026, GobyMeds expanded into tirzepatide and brand-name options, b…
- May 17Provider re-verified
Lemonaid Health review, re-verified
Lemonaid Health offers the credibility and medical rigor that comes with being one of the oldest telehealth platforms in the GLP-1 space. The physician-only prescribing and thorough intake process exceed most competitors. Pricing is the trade-off: the site advertises a $129 GLP-1…
- May 17Provider re-verified
WeightWatchers (Sequence) review, re-verified
WeightWatchers' GLP-1 program makes sense for users who already love WW and want to add medication, or those with insurance who can bring the cost down. The community and structured approach add genuine value for the right user. But at $74/mo for the MED+ membership ($20/mo for t…
- May 17Provider re-verified
Calibrate review, re-verified
Calibrate in 2026 is cleaner than it was: the $1,649 enrollment fee is gone, replaced by a $199/mo program fee with a 3-month commitment. Medication is separate, so the all-in total is not yet comparable with bundled providers. You still get the structured physician-led program (…
- May 17Provider re-verified
GoodRx Care review, re-verified
GoodRx Care is a convenient prescription pathway for users already in the GoodRx ecosystem, especially those with insurance. The discount integration is genuinely useful for finding the cheapest pharmacy prices. But as a GLP-1 program, it's bare-bones, no ongoing support, no medi…
- May 17Provider re-verified
Shed review, re-verified
Shed is the fastest way to start GLP-1 treatment, 2-3 days from signup to medication delivery is genuinely market-leading, and the 4.6/5 Trustpilot score across 766 reviews says the speed doesn't come at quality's expense. At $199/mo for compounded semaglutide with tirzepatide al…
- May 17Provider re-verified
Oak Longevity review, re-verified
Oak Longevity competes on price and billing freedom. The $119/mo compounded semaglutide and $185/mo tirzepatide figures match the comparison table verified July 31, 2026, and the manual-renewal model avoids automatic monthly charges. Brand-name tiers remain far above direct manuf…
- May 17Provider re-verified
Tonik Wellness review, re-verified
Tonik Wellness is a fair mid-tier compounded GLP-1 option with a clear strength (transparent six-tier monthly/quarterly/annual pricing on both semaglutide and tirzepatide) and a clear weakness (a 3-month minimum commitment plus final-sale rules that more flexible competitors like…
- May 17Provider re-verified
Novi review, re-verified
Novi is a credible upper-mid-tier compounded GLP-1 option with three clear strengths (six named clinicians, month-to-month billing with no commitment, aggressive $99-$133/mo introductory promo pricing) and the standard set of compounded-only weaknesses (no brand-name access, no o…
- May 17Provider re-verified
Wellorithm review, re-verified
Wellorithm earns its 7.4 with two genuinely uncommon features: compounded GLP-1 in oral dissolving tablet format alongside the standard injectable, and a 10% weight-loss money-back guarantee with up to four months of fees refundable if you don't hit the outcome target. Entry pric…
- May 17Provider re-verified
Bodybuilding Health+ review, re-verified
Bodybuilding Health+ pairs a competitively-priced compounded-GLP-1 menu ($179 sema, $209 tirz) with unusually good disclosure for its tier: a named medical advisor (Dr. Mark Rosenberg, M.D.) with verifiable anti-aging credentials, a disclosed operating entity (Dynamo Group LLC un…
- May 13Provider re-verified
Henry Meds review, re-verified
Henry Meds has the strongest verified customer-experience signal in our table, 12,461 Trustpilot reviews at 4.5 stars, 85% 5-star. Best for people who want a well-tested platform with the flexibility to switch between compounded and brand-name medications. The main transparency g…
- May 13Provider re-verified
Yucca Health review, re-verified
Yucca Health has the strongest customer-experience signal of any compounded GLP-1 provider we've checked: 4.6 stars across 1,065 Trustpilot reviews, two named board-certified doctors (rare in this category), and Klarna/Affirm/Afterpay financing to spread the 6-month plan. The $14…
- May 13Editorial / methodology
Publish-cadence cap announced
While at DR 0 with lifetime affiliate revenue below $500, new articles are capped at 2 per week. Every new article requires verified primary-source data, articles whose sources can't be independently checked are deferred, not shipped. The freed publishing capacity routes to revie…
- May 12Article shipped
IvyRx GLP-1 Review 2026: Flat-Rate Compounded Semaglutide & Tirzepatide at $175 to $297/mo
IvyRx offers compounded semaglutide from $175/month and tirzepatide from $275/month with a rare flat-rate model, your price never increases as your dose goes up. We reviewed their pricing, clinical oversight, and transparency. Key finding: the flat-rate pricing is genuinely valua…
- May 12Editorial / methodology
Embody review v2, full verification pass
Re-verified Embody end-to-end via live-site crawl: pricing, medical director, compounding pharmacy partners, customer evidence, aggregate review scores. Six logical chapters with sticky TOC, plain-English methodology, no jargon. The template replicated weekly on the next click-wi…
- May 9Editorial / methodology
Provider Anchor audit script + GATE 3
Every reference to a provider's price across the codebase now traces to providers.ts. The audit script flags any drift between the canonical price and stale references in blog posts or components. Wired into the pre-push gate so price changes can't ship without consistency.
- May 8Article shipped
FDA Proposes 503B Bulk-Compounding Exclusions for Semaglutide, Tirzepatide & Liraglutide
Verified May 8, 2026, Updated August 12, 2026: On April 30, FDA proposed excluding semaglutide, tirzepatide, and liraglutide from the list of bulk substances that 503B outsourcing facilities may use based on clinical need. The public comment period closed July 30, 2026 (Docket FD…
- May 7Article shipped
Tirzepatide Dosage Chart for Weight Loss 2026: Complete Schedule (Zepbound, Mounjaro & Compounded)
Verified May 2026: Tirzepatide starts at 2.5 mg once weekly (non-therapeutic starter dose), escalates by 2.5 mg every 4 weeks to a maximum of 15 mg once weekly. Full escalation takes 20 weeks. At 72 weeks, the 15 mg dose produced 20.9% body weight loss in SURMOUNT-1, equivalent t…
- May 5Article shipped
Next Weight Loss Drugs Pipeline (2026): Retatrutide 28.7%, CagriSema 22.7%, MariTide Monthly
Updated May 2026: 5 next-gen obesity drugs in Phase 3. Retatrutide (Lilly) 28.7% weight loss. CagriSema (Novo): REDEFINE-1 22.7% (obesity), REDEFINE-2 15.7% (T2D), PDUFA expected October 2026. MariTide (Amgen, monthly), survodutide, Foundayo approved April 2026. FDA approvals 202…
- May 4Editorial / methodology
Scoring rubric 2026, published
Five-axis weighted methodology (Cost 25%, Clinical 25%, Medication options 20%, UX 15%, Insurance 15%) with public scoring-evidence.json. 29 of 54 scores are computed from published evidence flags; the rest carry a legacy score and a documented status while the evidence is collec…
April 2026 · 21 entries
- April 29Article shipped
Foundayo (Orforglipron) Guide 2026: from $149/mo Self-Pay, 12.4% Weight Loss, No Fasting Required
Updated August 14, 2026: Foundayo (orforglipron) is Lilly's FDA-approved non-peptide GLP-1 pill. LillyDirect self-pay is $149 at 0.8 mg, $199 at 2.5 mg, $299 at 5.5 or 9 mg, and $299 at 14.5 or 17.2 mg with a refill within 45 days, otherwise $349. No fasting is required.
- April 23Editorial / methodology
First affiliate conversion
Eden Health, $300 payout. Validated the funnel: organic search → review page → affiliate click → conversion. The unit economics check out; the bottleneck is volume, not the funnel.
- April 22Article shipped
Zepbound vs Mounjaro (April 2026): Same Drug, Different Labels, Which Is Right for You?
Verified July 2026: Zepbound and Mounjaro are the exact same drug (tirzepatide) at the same doses. Mounjaro was FDA-approved May 2022 for Type 2 diabetes. Zepbound was FDA-approved November 2023 for chronic weight management and December 2024 for obstructive sleep apnea. List pri…
- April 20Article shipped
Zepbound Side Effects (2026): Nausea 29%, Diarrhea 23%, Vomiting 13%, Full Guide with SURMOUNT Trial Data
Verified July 2026: Zepbound (tirzepatide) side effects from the SURMOUNT clinical trials, nausea affects 24-29% of patients (vs 8% placebo), diarrhea 19-23%, vomiting 8-13%. Only 4.3% discontinued at the highest dose. GI symptoms peak during dose escalation and resolve within 4-…
- April 16Article shipped
RFK Jr. Proposes Medicare GLP-1 'Framework' (April 2026): Glucose Monitors First, Coverage Second
HHS Secretary Robert F. Kennedy Jr. is considering a regulatory framework for Medicare and Medicaid GLP-1 coverage, but only for patients who have 'exhausted other options', specifically glucose monitors (~$80/month), diet changes, and exercise. Verified April 2026: what Kennedy…
- April 13Article shipped
GLP-1 Receptor Agonists for Weight Loss 2026: FDA-Approved Options, Cost & Prescription Guide
FDA-approved GLP-1 receptor agonists for weight loss, 2026 guide. Eligibility: BMI 30+ (or 27+ with comorbidity). Semaglutide produces 14.9% weight loss (STEP-1), tirzepatide 20.9% (SURMOUNT-1). Cost: $25-$349/mo via telehealth. Complete 5-step prescription process with verified…
- April 11Article shipped
Brand vs Compounded GLP-1 (2026): Wegovy From $199 vs Compounded Options
Verified August 7, 2026: NovoCare lists the brand-name Wegovy pen at $199/mo for the first two low-dose fills, then $349/mo at standard strengths ($399 for HD) and the oral pill from $149/mo, dose-dependent; Zepbound starts at $299/mo via LillyDirect. Compounded offerings may adv…
- April 11Article shipped
First Month on GLP-1 (2026): 2-5 lbs Lost Week 1-4, Nausea Peaks Week 4, Week-by-Week
Verified July 2026: GLP-1 patients lose 2-5 pounds in their first month. Appetite suppression starts week 1-2. Nausea peaks at week 4 dose escalation. 98.1% of GI side effects are mild-to-moderate per STEP-1 and SURMOUNT-1 trials. Complete week-by-week timeline with dosing schedu…
- April 11Article shipped
Wegovy Pill vs Injection (2026): 16.6% vs 14.9% Weight Loss, From $149 vs $199/mo
Verified August 2026: Oral Wegovy (25mg daily pill) produced 16.6% weight loss in OASIS vs 14.9% for injectable Wegovy (2.4mg weekly) in STEP-1. NovoCare lists the pill from $149/mo and pen from $199/mo, prescription required and dose-dependent. Full cross-trial comparison.
- April 11Article shipped
Foods to Avoid on GLP-1 (2026): 7 Worst Offenders + What to Eat Instead
Verified July 2026: The 7 worst foods on Ozempic, Wegovy, Zepbound, fried food, sugary drinks, red meat portions, raw cruciferous veg, carbonated beverages, alcohol, high-fiber bars. GLP-1s slow gastric emptying 25-40%, triggering nausea in 44% of patients. Full list with alterna…
- April 11Article shipped
GLP-1 Side Effects (2026): Nausea 44%, Diarrhea 30%, Vomiting 24%, Complete Management Guide
Verified July 2026: 44% of Wegovy patients report nausea, 30% diarrhea, 24% vomiting in STEP-1 trial. Only 7% discontinued for side effects. Tirzepatide (Zepbound) is more tolerable: 24-33% nausea, 7-13% vomiting per SURMOUNT-1. Full management guide with red flags.
- April 11Article shipped
Tirzepatide Cost 2026: $149 to $1,086/Month, Every Option Ranked (Verified July 2026)
Verified August 2026: Tirzepatide prices include $149/mo via Gala on a yearly microdose plan ($169/mo for 3 months), $299/mo via LillyDirect (brand Zepbound 2.5mg vial), $399 for the 5mg vial, $449 for 7.5mg and higher doses when refill conditions are met, $25/mo with an eligible…
- April 11Article shipped
Compounded Tirzepatide in 2026: Prices, Safety Questions, and FDA Rules
Tirzepatide's shortage was resolved in October 2024 and shortage-based enforcement discretion ended in early 2025. This guide compares advertised compounded prices with brand Zepbound and explains why legality, formulation, and safety cannot be inferred from availability alone.
- April 11Article shipped
Zepbound & Mounjaro Savings Card (2026): $25/mo Copay + $1,300 Annual Savings
Verified July 2026: Zepbound savings card cuts copay to $25/fill ($1,300 max annual savings) with commercial insurance. Mounjaro savings card offers $25 copay for T2D. Both expire Dec 31, 2026. Activate in 2 minutes at zepbound.lilly.com/savings. Full eligibility + backup options…
- April 11Article shipped
Foundayo Ships Week 2: How to Order Eli Lilly's GLP-1 Pill Right Now (April 2026)
Launch record updated August 14, 2026: Foundayo began shipping April 6. Its $649 figure is WAC/list price, not the current LillyDirect self-pay total. Cash pricing now runs $149-$349 by dose and refill timing; eligible commercial-insurance savings may lower the copay.
- April 11Article shipped
FDA GLP-1 Warning Letters: How to Read the Sourced Record
A source-bounded guide to FDA warning letters involving compounded GLP-1 marketing, labeling, and manufacturing. Our linked tracker is finite and does not certify safety or compliance.
- April 10Editorial / methodology
Canonical tags on every page
Next.js App Router does not emit canonicals automatically from metadataBase, every route now explicitly exports alternates.canonical via metadata or generateMetadata. GATE 4 enforces this pre-push for any new template.
- April 10Editorial / methodology
Provider count 40 → 46 → 48
Expanded coverage to include Yucca Health, Gala, Embody, Bodybuilding Health+, and others. Every comparison page is template-generated, so n × (n-1) / 2 matchups stay in sync automatically.
- April 8Article shipped
GLP-1 Patches for Weight Loss: Do They Actually Work? (2026 Fact Check)
GLP-1 patches sold online don't contain semaglutide or tirzepatide, they're herbal supplements. Here's what the science says and what actually works.
- April 3Article shipped
Ro vs Hims for GLP-1 Weight Loss: Which Is Better in 2026?
Two of the biggest telehealth platforms now offer branded Wegovy and GLP-1 programs. We compare Ro and Hims on pricing, medications, insurance, clinical support, and what actually changed after the Novo Nordisk lawsuit.
- April 2Article shipped
Foundayo (Orforglipron) FDA Approved: The First GLP-1 Weight Loss Pill You Can Take Anytime
The FDA just approved Eli Lilly's Foundayo (orforglipron), the only GLP-1 weight loss pill with no food, water, or timing restrictions. Here's what it costs, how it works, and how it compares to Wegovy and Zepbound.